![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » C4Diagnostics’ COVID-19 Rapid Saliva Test Cleared in Europe
C4Diagnostics’ COVID-19 Rapid Saliva Test Cleared in Europe
![C4Diagnostics logo](https://www.fdanews.com/ext/resources/test/Drug-Images4/C4Diagnostics-logo.gif?t=1619644203&width=430)
C4Diagnostics has obtained CE mark certification for C4Covid-19 Human, a rapid coronavirus diagnostic that uses saliva samples to detect infection.
The in vitro diagnostic test is used with a portable reader-analyzer device to deliver test results in under 30 minutes.
C4Diagnostics says the test, which is based on reverse transcription loop-mediated isothermal amplification technology, offers performance comparable with reverse transcription polymerase chain reaction (RT-PCR) analyses of nasopharyngeal swabs.
Upcoming Events
-
21Oct